SSA
DXCM icon

Schonfeld Strategic Advisors’s DexCom DXCM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.6M Sell
152,930
-237,529
-61% -$16.5M 0.07% 308
2025
Q4 		$25.9M Buy
390,459
+25,759
+7% +$1.67M 0.11% 149
2025
Q3 		$24.5M Buy
364,700
+330,068
+953% +$26.1M 0.14% 145
2025
Q2 		$3.02M Buy
34,632
+15,833
+84% +$1.24M 0.02% 780
2025
Q1 		$1.28M Sell
18,799
-128,493
-87% -$10.5M 0.01% 1176
2024
Q4 		$11.5M Buy
147,292
+135,920
+1,195% +$10.1M 0.07% 269
2024
Q3 		$762K Sell
11,372
-53,574
-82% -$4.4M 0.01% 1253
2024
Q2 		$7.36M Buy
64,946
+5,904
+10% +$746K 0.05% 438
2024
Q1 		$8.19M Sell
59,042
-19,841
-25% -$2.49M 0.05% 452
2023
Q4 		$9.79M Sell
78,883
-224,764
-74% -$23M 0.06% 358
2023
Q3 		$28.3M Buy
303,647
+227,445
+298% +$25.6M 0.22% 113
2023
Q2 		$9.79M Sell
76,202
-15,338
-17% -$1.86M 0.08% 341
2023
Q1 		$10.6M Buy
91,540
+32,739
+56% +$3.66M 0.1% 271
2022
Q4 		$6.66M Buy
58,801
+40,601
+223% +$4.46M 0.06% 401
2022
Q3 		$1.47M Sell
18,200
-45,860
-72% -$3.88M 0.01% 1038
2022
Q2 		$4.77M Buy
64,060
+24,336
+61% +$2.22M 0.05% 489
2022
Q1 		$5.08M Sell
39,724
-41,420
-51% -$4.53M 0.05% 443
2021
Q4 		$10.9M Buy
81,144
+31,352
+63% +$4.51M 0.1% 269
2021
Q3 		$6.81M Buy
49,792
+29,944
+151% +$3.78M 0.07% 354
2021
Q2 		$2.12M Buy
19,848
+11,448
+136% +$1.1M 0.02% 688
2021
Q1 		$755K Sell
8,400
-40,400
-83% -$3.79M 0.01% 992
2020
Q4 		$4.51M Buy
48,800
+43,600
+838% +$3.89M 0.06% 414
2020
Q3 		$536K Sell
5,200
-42,536
-89% -$4.44M 0.01% 893
2020
Q2 		$4.84M Buy
47,736
+27,336
+134% +$2.45M 0.12% 237
2020
Q1 		$1.37M Sell
20,400
-2,864
-12% -$178K 0.09% 279
2019
Q4 		$1.27M Sell
23,264
-82,340
-78% -$3.91M 0.03% 444
2019
Q3 		$3.94M Buy
105,604
+52,404
+99% +$2.04M 0.12% 194
2019
Q2 		$1.99M Sell
53,200
-248,400
-82% -$7.81M 0.07% 287
2019
Q1 		$8.98M Buy
301,600
+139,200
+86% +$4.89M 0.31% 79
2018
Q4 		$4.86M Buy
162,400
+14,800
+10% +$469K 0.19% 152
2018
Q3 		$5.28M Buy
147,600
+113,960
+339% +$3.53M 0.23% 124
2018
Q2 		$799K Sell
33,640
-91,892
-73% -$1.95M 0.04% 435
2018
Q1 		$2.33M Sell
125,532
-397,788
-76% -$5.88M 0.17% 166
2017
Q4 		$7.51M Buy
523,320
+136,960
+35% +$1.78M 0.61% 30
2017
Q3 		$4.73M Buy
386,360
+175,116
+83% +$3.1M 0.43% 69
2017
Q2 		$3.86M Buy
+211,244
New +$3.9M 0.4% 57
2017
Q1 		– Sell
-40,000
Closed -$597K – 627
2016
Q4 		$597K Buy
+40,000
New +$709K 0.08% 306

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schonfeld Strategic Advisors's DXCM Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its DexCom (DXCM) stake by 61% in Q1 2026, selling an estimated $16.5M and leaving 152,930 shares worth $9.6M. The position accounts for 0.07% of the portfolio, ranked #308.

Schonfeld Strategic Advisors first reported a position in DXCM in Q4 2016 and has held it in 37 quarters since. The position peaked at $28.3M in Q3 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Schonfeld Strategic Advisors held 152,930 shares of DexCom worth $9.6M as of Q1 2026.
  • Schonfeld Strategic Advisors sold 237,529 DexCom shares in Q1 2026, an estimated $16.5M.
  • DexCom made up 0.07% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #308 holding.
  • Schonfeld Strategic Advisors first reported a position in DexCom in Q4 2016 and has held it in 37 quarters since.
  • Schonfeld Strategic Advisors's DexCom position peaked at $28.3M in Q3 2023.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.